The premotor phase of Parkinson's disease

Parkinsonism and Related Disorders

Volumn 13, Issue SUPPL. SEPT., 2007, Pages

  Tolosa, E ^a   Compta, Y ^a   Gaig, C ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Diagnostic implications; Non motor symptoms; Parkinson's disease; Premotor pathology; Premotor phase

Indexed keywords

ARTICLE; CONSTIPATION; DEPRESSION; DISEASE ACTIVITY; DISEASE COURSE; HUMAN; MOOD DISORDER; PARKINSON DISEASE; PRIORITY JOURNAL; SLEEP DISORDER; SMELLING DISORDER; SYMPTOM;

CONSTIPATION; HUMANS; MOOD DISORDERS; OLFACTION DISORDERS; PARKINSON DISEASE; REM SLEEP BEHAVIOR DISORDER; RISK FACTORS;

EID: 34548860077     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2007.06.007     Document Type: Article

References (97)

1. de Lau L.M., Koudstaal P.J., Hofman A., and Breteler M.M. Subjective complaints precede Parkinson disease: the Rotterdam study. Arch Neurol 63 (2006) 362-365
2. Abbott R.D., Ross G.W., White L.R., et al. Environmental, life-style, and physical precursors of clinical Parkinson's disease: recent findings from the Honolulu-Asia aging study. J Neurol 250 Suppl 3 (2003) 30-39
3. Braak H., Del Tredici K., Rub U., de Vos R.A., Jansen Steur E.N., and Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24 (2003) 197-211
4. Iranzo A., Molinuevo J.L., Santamaría J., Serradell M., Martí M.J., Valldeoriola F., et al. Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol 5 (2006) 572-577
5. Gonera E.G., Van't Hof M., Berger H.J.C., Van Weel C., and Horstink M.W.I.M. Symptoms and duration of the premotor phase in Parkinson's disease. Mov Disord 12 (1997) 871-876
6. Becker G., Müller A., Braune S., et al. Early diagnosis of Parkinson's disease. J Neurol Suppl 3 (2002) 40-48
7. Hornykiewicz O., and Kish S.J. Biochemical pathophysiology of Parkinson's disease. Adv Neurol 45 (1987) 19-34
8. Riederer P., and Wuketich S. Time course of nigrostriatal degeneration in parkinson's disease. A detailed study of influential factors in human brain amine analysis. J Neural Transm 38 (1976) 277-301
9. 123I]b-CIT SPECT. J Neurol 245 (1998) 14-20
10. Tissingh G., Booij J., Bergmans P., Winogrodzka A., Janssen A.G., van Royen E.A., et al. Iodine-123-N-vfluoropropyl-2b-carbomethoxy-3b-[4-iodophenyl]tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease. J Nucl Med 39 (1998) 1143-1148
11. 123I]B-CIT SPECT imaging assessment of the rate of Parkinson's disease progression. Neurology 57 (2001) 2089-2094
12. 18F]dopa PET. J Neurol Neurosurg Psychiatry 64 (1998) 314-319
13. Fearnley J.M., and Lees A.J. Ageing and Parkinson's disease: SN regional selectivity. Brain 114 (1991) 2283-2301
14. Chaudhuri K.R., Daniel G., Healy D.G., and Schapira A.H.V. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 5 (2006) 235-245
15. Awerbuch G.I., and Sandyk R. Autonomic functions in the early stages of Parkinson's disease. Int J Neurosci 74 (1994) 9-16
16. Abbott R.D., Petrovitch H., White L.R., Masaki K.H., Tanner C.M., Curb J.D., et al. Frequency of bowel movements and the future risk of Parkinson's disease. Neurology 57 (2001) 456-462
17. Kaufmann H., and Biaggioni I. Autonomic failure in neurodegenerative disorders. Semin Neurol 23 (2003) 351-363
18. Magerkurth C., Schnitzer R., and Braune S. Symptoms of autonomic failure in Parkinson's disease: prevalence and impact on daily life. Clin Auton Res 15 (2005) 76-82
19. Ashraf W., Pfeiffer R.F., Park F., Lof J., and Quigley E.M. Constipation in Parkinson's disease: objective assessment and response to psyllium. Mov Disord 12 (1997) 946-951
20. Camilleri M., and Bharucha A.E. Gastrointestinal dysfunction in neurologic disease. Semin Neurol 16 (1996) 203-216
21. Visser M., Marinus J., Stiggelbout A.M., and Van Hilten J.J. Assessment of autonomic dysfunction in Parkinson's disease: the SCOPA-AUT. Mov Disord 19 (2004) 1306-1312
22. Ueki A., and Otsuka M. Life style risks of Parkinson's disease: association between decreased water intake and constipation. J Neurol 251 Suppl 7 (2004) 18-23
23. Kaye J., Gage J., Kimber A., Storey L., and Trend P. Excess burden of constipation in Parkinson's disease: a pilot study. Mov Disord 21 (2006) 1270-1273
24. Braak H., de Vos R.A., Bohl J., and Del Tredici K. Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neurosci Lett 396 (2006) 67-72
25. Kupsky W.J., Grimes M.M., Sweeting J., Bertsch R., and Cote L.J. Parkinson's disease and megacolon: concentric hyaline inclusions (Lewy bodies) in enteric ganglion cells. Neurology 37 (1987) 1253-1255
26. Rosenthal M.J., and Marshall C.E. Sigmoid volvulus in association with parkinsonism. Report of four cases. J Am Geriatr Soc 35 (1987) 683-684
27. Pfeiffer R.F. Gastrointestinal dysfunction in Parkinson's disease. Lancet Neurol 2 (2003) 107-116
28. Edwards L.L., Pfeiffer R.F., Quigley E.M.M., Hofman R., and Baluff M. Gastrointestinal symptoms in Parkinson's disease. Mov Disord 6 (1991) 151-156
29. McCallum R.W., and Brown R.L. Diabetic and nondiabetic gastroparesis. Curr Treat Options Gastroenterol 1 (1998) 1-7
30. Mathers S.E., Kempster P.A., Swash M., and Lees A.J. Constipation and paradoxical puborectalis contraction in anismus and Parkinson's disease: a dystonic phenomenon?. J Neurol Neurosurg Psychiatry 51 (1988) 1503-1507
31. Jackson M., Lennox G., Balsitis M., and Lowe J. Lewy body dysphagia. J Neurol Neurosurg Psychiatry 58 (1995) 756-758
32. Qualman S.J., Haupt H.M., Yang P., and Hamilton S.R. Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson's disease. Gastroenterology 87 (1984) 848-856
33. Singer C., Weiner W.J., Sanchez-Ramos J.R., and Ackerman M. Sexual dysfunction in men with Parkinson's disease. J Neurol Rehab 3 (1989) 199-204
34. Welsh M., Hung L., and Waters C.H. Sexuality in women with Parkinson's disease. Mov Disord 12 (1997) 923-927
35. Wermuth L., and Stenager E. Sexual problems in young patients with Parkinson's disease. Acta Neurol Scand 91 (1995) 453-455
36. Bronner G., Royter V., Korczyn A.D., and Giladi N. Sexual dysfunction in Parkinson's disease. J Sex Marital Ther 30 (2004) 95-105
37. Goldstein D.S. Dysautonomia in Parkinson's disease: neurocardiological abnormalities. Lancet Neurol 2 (2003) 669-676
38. Kaufmann H., Nahm K., Purohit D., and Wolfe D. Autonomic failure as the initial presentation of Parkinson disease and dementia with Lewy bodies. Neurology 63 (2004) 1093-1095
39. Aranda B. Vesical sphincter disorders in Parkinson disease. Rev Neurol 149 (1993) 476-480
40. Wenning G.K., Scherfler C., Granata R., Bosch S., Verny M., Chaudhuri K.R., et al. Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed Parkinsonian syndromes: a clinicopathological study. J Neurol Neurosurg Psychiatry 67 (1999) 620-623
41. Compta Y., Marti M.J., Paredes P., and Tolosa E. Pure autonomic failure with altered dopamine transporter imaging. Arch Neurol 63 (2006) 604-605
42. Braune S. The role of cardiac metaiodobenzylguanidine uptake in the differential diagnosis of Parkinsonian syndromes. Clin Auton Res 11 (2001) 351-355
43. Ansari K.A., and Johnson A. Olfactory function in patients with Parkinson's disease. J Chronic Dis 28 (1975) 493-497
44. Ward C.D., Hess W.A., and Calne D.B. Olfactory impairment in Parkinson's disease. Neurology 33 (1983) 943-946
45. Quinn N.P., Rossor M.N., and Marsden C.D. Olfactory threshold in Parkinson's disease. J Neurol Neurosurg Psychiatry 50 (1987) 88-89
46. Doty R.L., Deems D.A., and Stellar S. Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 38 (1988) 1237-1244
47. Doty R.L., Stern M.B., Pfeiffer C., Gollomp S.M., and Hurtig H.I. Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 55 (1992) 138-142
48. Tissingh G., Berendse H.W., Bergmans P., DeWaard R., Drukarch B., Stoof J.C., et al. Loss of olfaction in de novo and treated Parkinson's disease: possible implications for early diagnosis. Mov Disord 16 (2001) 41-46
49. Hawkes C.H., Shephard B.C., and Daniel S.E. Olfactory dysfunction in Parkinson's disease. J Neurol Neurosurg Psychiatry 62 (1997) 436-446
50. Stern M., Doty R.L., Dotti M., Corcoran P., Crawford D., McKeown D.A., et al. Olfactory function in Parkinson's disease subtypes. Neurology 44 (1994) 266-268
51. Henderson J.M., Lu Y., Wang S., Cartwright H., and Halliday G.M. Olfactory deficits and sleep disturbances in Parkinson's disease: a case-control survey. J Neurol Neurosurg Psychiatry 74 (2003) 956-958
52. Ross W., Petrovitch H., Abbott R.D., et al. Association of olfactory dysfunction with risk of future Parkinson's disease. Mov Disord 20 Suppl 10 (2005) 129-130
53. Ross G.W., Abbott R.D., Petrovitch H., Tanner C.M., Davis D.G., Nelson J., et al. Association of olfactory dysfunction with incidental Lewy bodies. Mov Disord 21 (2006) 2062-2067
54. Sommer U., Hummel T., Cormann K., Mueller A., Frasnelli J., Kropp J., et al. Detection of presymptomatic Parkinson's disease: combining smell tests, transcranial sonography, and SPECT. Mov Disord 19 (2004) 1196-1202
55. Markopoulou K., Larsen K.W., Wszolek E.K., Denson M.A., Lang A.E., Pfeiffer R.F., et al. Olfactory dysfunction in familial Parkinsonism. Neurology 49 (1997) 1262-1267
56. Montgomery E.B., Baker K.B., Lyons K., and Koller W.C. Abnormal performance on the PD test battery by asymptomatic first degree relatives. Neurology 52 (1999) 757-762
57. Berendse H.W., Booij J., Francot G.M.J.E., Bergmans P.L., Hijman R., Stoof J.C., et al. Subclinical dopaminergic dysfunction in a symptomatic Parkinson's disease patients' relatives with a decreased sense of smell. Ann Neurol 50 (2001) 34-41
58. Ponsen M.M., Stoffers D., Booij J., van Eck-Smit B.L., Wolters E.C.h., and Berendse H.W. Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol 56 (2004) 173-181
59. Marras C., Goldman S., Smith A., Barney P., Aston D., Comyns K., et al. Smell identification ability in twin pairs discordant for Parkinson's disease. Mov Disord 20 (2005) 687-693
60. Nausieda P.A. Sleep in Parkinson's disease. In: Koller W.C. (Ed). Handbook of Parkinson's disease (1992), Marcel Dekker Inc., New York 451-467
61. Lees A.J., Blackburn N.A., and Campbell V.L. The nighttime problems of Parkinson's disease. Clin Neuropharmacol 11 (1998) 512-519
62. Factor S.A., Mc Alarney T., Sánchez-Ramos J.R., and Weiner W.J. Sleep disorders and sleep effect in Parkinson's disease. Mov Disord 5 (1990) 280-285
63. Tandberg E., Larsen J.P., and Karlsen K. A community-based study of sleep disorders in patients with Parkinson's disease. Mov Disord 13 (1998) 895-899
64. Stocchi F., Vacca L., Valente M., and Ruggieri S. Sleep disorders in Parkinson's disease. Adv Neurol 86 (2001) 289-293
65. Oerlemans W.G.H., and de Weerd A.I.W. The prevalence of sleep disorders in patients with Parkinson's disease. A self-reported, community-based survey. Sleep Med 3 (2002) 147-149
66. Boeve B.F., Silber M.H., Ferman T.J., Lucas J.A., and Parisi J.E. Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleopathy. Mov Disord 16 (2001) 622-630
67. Schenk C.H., and Mahowald M.W. REM sleep behaviour disorder: clinical, developmental and neuroscience perspectives 16 years after its formal identification in SLEEP. Sleep 25 (2002) 120-138
68. Postuma R.B., Lang A.E., Massicotte-Marquez J., and Montplaisir J. Potential early markers of Parkinson's disease in idiopathic REM sleep behavior disorder. Neurology 66 (2006) 845-851
69. Stiasny-Kolster K., Doerr Y., Möller J.C., Hoffken H., Behr T.M., Oertel W.H., et al. Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alfa-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain 128 (2005) 126-137
70. Frucht S.J., Rogers M.D., Greene P.E., Gordon M.F., and Fahn S. Falling sleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology 52 (1999) 1908-1910
71. Hobson D.E., Lang A.E., Martin W.R., Razmy A., Riwest J., and Fleming J. Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease. A survey by the Canadian movement disorder group. JAMA 287 (2002) 455-463
72. Abbott R.D., Ross G.W., White L.R., Tanner C.M., Masaki K.H., Nelson J.S., et al. Excessive daytime sleepiness and subsequent development of Parkinson disease. Neurology 65 (2005) 1442-1446
73. Santamaria J., Tolosa E., and Valles A. Parkinson's disease with depression: a possible subgroup of idiopathic parkinsonism. Neurology 36 (1986) 1130-1133
74. Dooneief G., Mirabello E., Bell K., Marder K., Stern Y., and Mayeux R. An estimate of the incidence of depression in idiopathic Parkinson's disease. Arch Neurol 49 (1992) 305-307
75. Tandberg E., Larsen J.P., Aarsland D., and Cummings J.L. The occurrence of depression in Parkinson's disease; a community based study. Arch Neurol 53 (1996) 175-179
76. Cummings J.L. Depression and Parkinson's disease: a review. Am J Psychiatry 149 (1992) 443-454
77. Slaughter J.R., Slaughter K.A., Nichols D., Holmes S.E., and Martens M.P. Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinson's disease. J Neuropsychiatry Clin Neurosci 13 (2001) 187-196
78. Burn D.J. Beyond the iron mask: towards better recognition and treatment of depression associated with Parkinson's disease. Mov Disord 17 (2002) 445-454
79. Robins A.H. Depression in patients with Parkinsonism. Br J Psychiatry 128 (1976) 141-145
80. Lieberman A. Depression in Parkinson's disease-a review. Acta Neurol Scand 113 (2006) 1-8
81. Montgomery E.B., Koller W.C., LaMantia T.J., Newman M.C., Swanson-Hyland E., Kaszniak A.W., et al. Early detection of probable idiopathic Parkinson's disease: I. Development of a diagnostic test battery. Mov Disord 15 (2000) 467-473
82. Montgomery Jr. E.B., Lyons K., and Koller W.C. Early detection of probable idiopathic Parkinson's disease: II. A prospective application of a diagnostic test battery. Mov Disord 15 (2000) 474-478
83. Nilsson F.M., Kessing L.V., and Bolwig T.G. Increased risk of developing Parkinson's disease for patients with major affective disorder: a register study. Acta Psychiatr Scand 104 (2001) 380-386
84. Nilsson F.M., Kessing L.V., and Sorensen T.M. Major depressive disorder in Parkinson's disease: a register-based study. Acta Psychiatr Scand 106 (2002) 202-211
85. Schuurman A.G., van den Akker M., Ensinck K.T., Metsemakers J.F., Knottnerus J.A., Leentjens A.F., et al. Increased risk of Parkinson's disease after depression: a retrospective cohort study. Neurology 58 (2002) 1501-1504
86. Leentjens A.F., Van den Akker M., Metsemakers J.F., Lousberg R., and Verhey F.R. Higher incidence of depression preceding the onset of Parkinson's disease: a register study. Mov Disord 18 (2003) 414-418
87. Lauterbach E.C., Freeman A., and Vogel R.L. Differential DSM-III psychiatric disorder prevalence and profiles in dystonia and Parkinson's disease. J Neuropsychiatry Clin Neurosci 16 (2004) 29-36
88. Ishihara L., and Brayne C. A systematic review of depression and mental illness preceding Parkinson's disease. Acta Neurol Scand 113 (2006) 211-220
89. Mindham R.H. Psychiatric symptoms in Parkinsonism. J Neurol Neurosurg Psychiatry 33 (1970) 188-191
90. Shiba M., Bower J.H., Maraganore D.M., McDonnell S.K., Peterson B.J., Ahlskog J.E., et al. Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study. Mov Disord 15 (2000) 669-677
91. Aarsland D., Larsen J.P., Lim N.G., Janvin C., Karlsen K., Tandberg E., et al. Range of neuropsychiatric disturbances in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 67 (1999) 492-496
92. Marsh L. Anxiety disorders in Parkinson's disease. Int Rev Psychiatry 12 (2000) 307-318
93. Weisskopf M.G., Chen H., Schwarzschild M.A., Kawachi I., and Ascherio A. Prospective study of phobic anxiety and risk of Parkinson's disease. Mov Disord 18 (2003) 646-651
94. Cooper J.A., Sagar H.J., Jordan N., Harvey N.S., and Sullivan E.V. Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain 114 (1991) 2095-2122
95. Pearce R.K., Hawkes C.H., and Daniel S.E. The anterior olfactory nucleus in Parkinson's disease. Mov Disord 10 (1995) 283-287
96. Del Tredici K., Rub U., de Vos R.A., et al. Where does Parkinson's disease pathology begin in the brain?. J Neuropathol Exp Neurol 61 (2002) 413-426
97. Remy P., Doder M., Lees A., Turjanski N., and Brooks D. Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 128 (2005) 1314-1322